Bioventus Inc (BVS) USD0.001 A

Sell:$7.50Buy:$8.57$0.08 (1.03%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$7.50
Buy:$8.57
Change:$0.08 (1.03%)
Market closed | Prices delayed by at least 15 minutes
Sell:$7.50
Buy:$8.57
Change:$0.08 (1.03%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Key people

Robert E. Claypoole
President, Chief Executive Officer, Director
Mark Singleton
Chief Financial Officer, Senior Vice President
Katrina Church
Senior Vice President, Chief Compliance Officer
Anthony D'adamio
Senior Vice President, General Counsel
William A. Hawkins
Non-Executive Independent Chairman of the Board
John A. Bartholdson
Independent Director
Patrick J. Beyer
Independent Director
Philip G. Cowdy
Independent Director
Mary Katherine Ladone
Independent Director
Click to see more

Key facts

  • EPIC
    BVS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US09075A1088
  • Market cap
    $622.51m
  • Employees
    930
  • Shares in issue
    66.23m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.